WT1-AS: A Potential Drug Target and Biomarker for Various Diseases

Target Name: WT1-AS

NCBI ID: G51352

WT1-AS: A Potential Drug Target and Biomarker for Various Diseases

WT1-AS (WT1-Actinin-1) is a protein that is expressed in various tissues of the body, including the brain, pancreas, and muscle. It is a key regulator of the actinin complex, a protein that is involved in many cellular processes in the cell.

Recent studies have identified WT1-AS as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because WT1-AS has been shown to play a role in the development and progression of these diseases , and may be a useful target for therapeutic intervention.

One of the reasons for the potential of WT1-AS as a drug target is its involvement in the regulation of actinin dynamics. Actinins are a type of protein that is involved in the regulation of cell division, and are essential for the proper execution of many cellular processes. WT1-AS is a key regulator of actinin dynamics, and has been shown to play a role in the regulation of cell division, cell migration, and the formation of tissues.

In addition to its role in actinin dynamics, WT1-AS has also been shown to be involved in the regulation of many other cellular processes. For example, it has been shown to play a role in the regulation of protein synthesis, cell signaling, and the development of cancer.

WT1-AS has also been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that high levels of WT1-AS are associated with the development of pancreatic cancer, and that inhibition of WT1- AS has been shown to be effective in the treatment of pancreatic cancer.

In addition to its potential as a drug target, WT1-AS has also been shown to be a useful biomarker for the diagnosis and prognosis of various diseases. For example, studies have shown that elevated levels of WT1-AS are associated with poor prognosis in patients with colorectal cancer, and that inhibition of WT1-AS has been shown to be effective in the treatment of colorectal cancer.

Overall, WT1-AS is a protein that has been shown to play a role in the regulation of actinin dynamics and many other cellular processes. Its potential as a drug target and biomarker make it an attractive target for therapeutic intervention in a wide range of diseases . Further research is needed to fully understand the role of WT1-AS in these diseases and to develop effective treatments.

Protein Name: WT1 Antisense RNA

More Common Targets